SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-147015
Filing Date
2024-05-24
Accepted
2024-05-24 16:02:30
Documents
13
Period of Report
2024-05-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d832581d8k.htm   iXBRL 8-K 37684
  Complete submission text file 0001193125-24-147015.txt   160087

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dawn-20240523.xsd EX-101.SCH 2857
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE dawn-20240523_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dawn-20240523_pre.xml EX-101.PRE 11266
16 EXTRACTED XBRL INSTANCE DOCUMENT d832581d8k_htm.xml XML 3654
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40431 | Film No.: 24984152
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)